Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Safety and Efficacy of Adjunctive Catheter-Directed Thrombolysis During Primary PCI for ST-segment Elevation Myocardial Infarction With High Thrombus Burden

Satsuki Noma
,
Hideki Miyachi
* ORCID logo ,
Isamu Fukuizumi
,
Junya Matsuda
,
Hideto Sangen
,
Yoshiaki Kubota
,
Yoichi Imori
,
Yoshiyuki Saiki
,
Yusuke Hosokawa
,
Shuhei Tara
,
Yukichi Tokita
,
Koichi Akutsu
,
Wataru Shimizu
,
Takeshi Yamamoto
,
Hitoshi Takano
Version 1 : Received: 19 October 2021 / Approved: 20 October 2021 / Online: 20 October 2021 (12:53:10 CEST)

How to cite: Noma, S.; Miyachi, H.; Fukuizumi, I.; Matsuda, J.; Sangen, H.; Kubota, Y.; Imori, Y.; Saiki, Y.; Hosokawa, Y.; Tara, S.; Tokita, Y.; Akutsu, K.; Shimizu, W.; Yamamoto, T.; Takano, H. Safety and Efficacy of Adjunctive Catheter-Directed Thrombolysis During Primary PCI for ST-segment Elevation Myocardial Infarction With High Thrombus Burden. Preprints 2021, 2021100293. https://doi.org/10.20944/preprints202110.0293.v1 Noma, S.; Miyachi, H.; Fukuizumi, I.; Matsuda, J.; Sangen, H.; Kubota, Y.; Imori, Y.; Saiki, Y.; Hosokawa, Y.; Tara, S.; Tokita, Y.; Akutsu, K.; Shimizu, W.; Yamamoto, T.; Takano, H. Safety and Efficacy of Adjunctive Catheter-Directed Thrombolysis During Primary PCI for ST-segment Elevation Myocardial Infarction With High Thrombus Burden. Preprints 2021, 2021100293. https://doi.org/10.20944/preprints202110.0293.v1

Abstract

Background: High coronary thrombus burden has been associated with unfavorable outcomes in patients with ST-segment elevation myocardial infarction (STEMI), the optimal management of which has not yet to be established. Methods: We evaluated the safety and efficacy of adjunctive catheter-directed thrombolysis (CDT) during primary percutaneous coronary intervention (PCI) in patients with STEMI and high thrombus burden. Results: Among the 1,849 consecutive patients with STEMI, 263 had high thrombus burden. Moreover, 41 patients received intracoronary infusion of tissue plasminogen activator during primary PCI (CDT group), whereas 222 did not receive (non-CDT group). No significant differences in bleeding complications and in-hospital and long-term mortalities were observed (9.8% vs. 7.2%, p=0.53; 7.3% vs. 2.3%, p=0.11; and 12.6% vs. 17.5%, p=0.84, CDT vs. non-CDT). In patients who underwent antecedent aspiration thrombectomy during PCI (75.6%; CDT group and 87.4%; non-CDT group), thrombolysis in myocardial infarction grade 2 or 3 flow rate after thrombectomy was significantly lower in the CDT group than in the non-CDT group (32.2% vs. 61.0%, p<0.01). However, the final rates improved considerably without significant difference (90.3% vs. 97.4%, p=0.14). Conclusions: For STEMI patients with high thrombus burden, adjunctive CDT is safe and effective for improving coronary flow. CDT resulted in favorable coronary flow even after unsatisfactory aspiration thrombectomy.

Keywords

high coronary thrombus burden; tissue plasminogen activator; catheter-directed thrombolysis

Subject

Medicine and Pharmacology, Cardiac and Cardiovascular Systems

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download PDF

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0
Get PDF Cite Share 0
Bookmark BibSonomy Mendeley Reddit Delicious
×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.